BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
5/19/2015 5:28:00 PM | Browse: 393 | Download: 524
Publication Name World Journal of Hepatology
Manuscript ID 13875
Country of Manuscript Source United States
2014-09-05 08:05
Peer-Review Started
2014-09-05 08:52
To Make the First Decision
2014-11-27 12:20
Return for Revision
2014-12-02 14:45
2015-01-15 04:53
Second Decision
2015-02-10 16:20
Accepted by Journal Editor-in-Chief
Accepted by Company Editor-in-Chief
2015-02-12 14:45
Articles in Press
2015-02-12 14:45
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript
2015-04-30 11:06
Publish the Manuscript Online
2015-05-19 17:28
ISSN 1948-5182 (online)
Open Access This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Copyright © The Author(s) 2015. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7901 Stoneridge Drive, Suite 501, Pleasanton, CA 94588, USA
Website http://www.wjgnet.com
Specialty Gastroenterology and Hepatology
Manuscript Type Review
Article Title Hepatocellular carcinoma: From diagnosis to treatment
Manuscript Source Invited Manuscript
All Author List Abhijeet Waghray, Arvind R Murali and KV Narayanan Menon
Funding Agency and Grant Number
Correspondence To Dr. Abhijeet Waghray, MD, Department of Medicine, MetroHealth Medical Center/Case Western Reserve University, 2500 MetroHealth Drive, Cleveland, OH 44109, United States. awaghray@metrohealth.org
Keywords Hepatocellular carcinoma; Hepatitis C virus; Liver transplantation; Tumor ablation; Sorafenib
Core Tip Hepatocellular carcinoma (HCC) is a rising cause of cancer related mortality and viral causes of cirrhosis appear to be a major cause. Surveillance helps to detect early stage disease and treatment options are determined by stage of presentation. Three potentially curative options are radiofrequency ablation, liver transplantation and tumor resection. Emerging therapies such as drug-eluting beads-transarterial chemoembolization or sorafenib will continue to advance treatment options in HCC. The following will provide a concise review of HCC from prevention to treatment.
Publish Date 2015-05-19 17:28
Citation Waghray A, Murali AR, Menon KVN. Hepatocellular carcinoma: From diagnosis to treatment. World J Hepatol 2015; 7(8): 1020-1029
Url http://www.wjgnet.com/1948-5182/full/v7/i8/1020.htm
DOI http://dx.doi.org/10.4254/wjh.v7.i8.1020
Full Article (PDF) WJH-7-1020.pdf
Full Article (Word) WJH-7-1020.doc
Revised Manuscript 13875-Review.docx
Peer-review Report 13875-Peer-review(s).pdf
Answering Reviewers 13875-Answering reviewers.pdf
Scientific Misconduct Check 13875-Scientific misconduct check.pdf
Scientific Editor Work List 13875-Scientific editor work list.pdf
Conflict-of-Interest Disclosure Form 13875-Conflict-of-interest statement.pdf
Copyright License Agreement 13875-Copyright assignment.pdf